Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apremilast in Active RA with Concomitant TNF Inhibition
NCT01204138Phase 2Withdrawn
- Sponsor
- Stanford University
- Start
- Sep 2010
- Primary completion
- Aug 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of apremilast in rheumatoid arthritis (RA), sponsored by Stanford University. Planned start Sep 2010; status: withdrawn.
02
Drugs
apremilast
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01204138.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01204138.